Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR | P30968 | 12/20 | 0.86 |
| ▸ | DRD1 | P21728 | 1/20 | 0.74 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.74 |
| ▸ | MRGPRX2 | Q96LB1 | 1/20 | 0.74 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6053414 | 0.99 | GNRHR (0.86) | GNRHRDRD1OPRM1MRGPRX2ABCB11 | |
| Acetic Acid SCHEMBL33809 | 0.99 | GNRHR (0.88) | GNRHRDRD1OPRM1MRGPRX2ABCB11 | |
| Glycine SCHEMBL9408385 | 0.98 | GNRHR (0.84) | GNRHRDRD1OPRM1MRGPRX2ABCB11 | |
| Dopamine SCHEMBL7286916 | 0.95 | GNRHR (0.80) | GNRHRDRD1OPRM1MRGPRX2ABCB11 | |
| SCHEMBL28837464 | 0.95 | GNRHR (0.78) | GNRHRDRD1OPRM1MRGPRX2ABCB11 | |
| Ganirelix SCHEMBL719978 | 0.94 | GNRHR (0.98) | GNRHRDRD1OPRM1MRGPRX2ABCB11 | |
| Ganirelix SCHEMBL4405429 | 0.94 | GNRHR (0.98) | GNRHRDRD1OPRM1MRGPRX2ABCB11 | |
| Ganirelix SCHEMBL19712192 | 0.94 | GNRHR (0.98) | GNRHRDRD1OPRM1MRGPRX2ABCB11 | |
| Teverelix SCHEMBL3152088 | 0.93 | GNRHR (0.84) | GNRHRDRD1OPRM1MRGPRX2ABCB11 | |
| Cetrorelix SCHEMBL21174252 | 0.93 | GNRHR (0.84) | GNRHRDRD1OPRM1MRGPRX2ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15415 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746850-A1 | EXTENDED RELEASE DRUG-LOADED MICROPARTICLES | Ferring BV (NL) | 2026-05-27 | — | — | EP | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| EP-4525938-B1 | RADIOPHARMACEUTICAL COMPLEXES TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND ITS COMBINATIONS | BAYER AG (DE) | 2026-03-11 | — | — | EP | claimed |
| US-20260034192-A1 | USE OF GNRH ANTAGONISTS IN MAMMALS TO SYNCHRONIZE FOLLICULAR WAVE EMERGENCE | UNIV SASKATCHEWAN (CA) | 2026-02-05 | — | — | US | claimed |
| US-12533321-B2 | Polypeptide formulations for oral delivery | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2026-01-27 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-20260000678-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING, SUPPRESSING, OR TREATING SYMPTOM ASSOCIATED WITH PSEUDO-ALLERGIC REACTION | TAKASAKI UNIV OF HEALTH AND WELFARE (JP) | 2026-01-01 | — | — | US | claimed |
| WO-1998058657-A1 | GONADOTROPIN RELEASING HORMONE ANTAGONIST | AKZO NOBEL N.V. (NL) | 1998-12-30 | — | — | WO | claimed |
| CN-1200032-A | Method for producing implants containing biologically active peptides | DEGHENGHI ROMANO (CH) | 1998-11-25 | — | — | CN | claimed |
| EP-0858323-A1 | PROCESS TO MANUFACTURE IMPLANTS CONTAINING BIOACTIVE PEPTIDES | DEGHENGHI, Romano (CH) | 1998-08-19 | — | — | EP | claimed |
| US-5773032-A | Long-acting injection suspensions and a process for their preparation | ASTA MEDICA AKTIENGELLSCHAFT (DE) | 1998-06-30 | — | — | US | claimed |
| CN-1178463-A | Use of anti-oestrogens as male contraceptives | SCHERING AG (DE) | 1998-04-08 | — | — | CN | claimed |
| WO-1998009613-A1 | PROCESS TO MANUFACTURE IMPLANTS CONTAINING BIOACTIVE PEPTIDES | DEGHENGHI ROMANO (CH) | 1998-03-12 | — | — | WO | claimed |
| CN-1136779-A | Long-acting injection suspension and preparation method thereof | ASTA MEDICA AG (DE) | 1996-11-27 | — | — | CN | claimed |
| EP-0732934-A1 | LONG-ACTING INJECTION SUSPENSIONS AND A PROCESS FOR THEIR PREPARATION | ASTA Medica Aktiengesellschaft (DE) | 1996-09-25 | — | — | EP | claimed |
| WO-1995015767-A1 | LONG-ACTING INJECTION SUSPENSIONS AND A PROCESS FOR THEIR PREPARATION | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 1995-06-15 | — | — | WO | claimed |
| US-5212288-A | Luteinizing hormone-releasing hormone antagonists | SYNTEX (U.S.A.) INC. (US) | 1993-05-18 | — | — | US | claimed |